Bioline Rx reported $-3.03M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Arca Biopharma USD -31.82M 2.24M Mar/2026
Bio Path USD -270K 706K Mar/2026
Bioline Rx USD -3.03M 1.42M Jun/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025